Unknown

Dataset Information

0

Stakeholder Perspectives on the Development and Implementation of a Polypharmacy Management Program in Germany: Results of a Qualitative Study.


ABSTRACT: Structured management programs have been developed for single diseases but rarely for patients with multiple medications. We conducted a qualitative study to investigate the views of stakeholders on the development and implementation of a polypharmacy management program in Germany. Overall, we interviewed ten experts in the fields of health policy and clinical practice. Using content analysis, we identified inclusion criteria for the selection of suitable patients, the individual elements that should make up such a program, healthcare providers and stakeholders that should be involved, and factors that may support or hinder the program's implementation. All stakeholders were well aware of polypharmacy-related risks and challenges, as well as the urgent need for change. Intervention strategies should address all levels of care and include all concerned patients, caregivers, healthcare providers and stakeholders, and involved parties should agree on a joint approach.

SUBMITTER: Dinh TS 

PROVIDER: S-EPMC9319191 | biostudies-literature | 2022 Jul

REPOSITORIES: biostudies-literature

altmetric image

Publications

Stakeholder Perspectives on the Development and Implementation of a Polypharmacy Management Program in Germany: Results of a Qualitative Study.

Dinh Truc Sophia TS   Brueckle Maria-Sophie MS   González-González Ana Isabel AI   Witte Julian J   van den Akker Marjan M   Gerlach Ferdinand M FM   Muth Christiane C   On Behalf Of The Evita Study Group  

Journal of personalized medicine 20220707 7


Structured management programs have been developed for single diseases but rarely for patients with multiple medications. We conducted a qualitative study to investigate the views of stakeholders on the development and implementation of a polypharmacy management program in Germany. Overall, we interviewed ten experts in the fields of health policy and clinical practice. Using content analysis, we identified inclusion criteria for the selection of suitable patients, the individual elements that s  ...[more]

Similar Datasets

| S-EPMC4391591 | biostudies-literature
| S-EPMC10850999 | biostudies-literature
| S-EPMC9540973 | biostudies-literature
| S-EPMC7885569 | biostudies-literature
| S-EPMC9838847 | biostudies-literature
| 2361924 | ecrin-mdr-crc
| S-EPMC6343312 | biostudies-literature
| S-EPMC8235882 | biostudies-literature
| S-EPMC8374609 | biostudies-literature
| S-EPMC4858192 | biostudies-literature